McKenna Robert J
Department of Thoracic Surgery, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Semin Oncol. 2007 Jun;34(3):250-5. doi: 10.1053/j.seminoncol.2007.03.006.
Despite advancements in systemic treatment and the understanding of tumor biology, the mainstay for the treatment of lung cancer remains its resection. All patients with lung cancer should be considered surgical candidates until they are proven to have contraindications to resection. This article reviews preoperative assessment and the operative technique for the surgical treatment of lung cancer. As with other surgical specialties, thoracic surgery is moving towards minimally invasive techniques that are reducing morbidity, mortality, and length of stay. This advance is allowing patients an earlier recovery from major pulmonary surgery.
尽管在全身治疗和肿瘤生物学认识方面取得了进展，但肺癌治疗的主要手段仍然是手术切除。所有肺癌患者在被证明有手术切除禁忌证之前，都应被视为手术候选者。本文回顾了肺癌手术治疗的术前评估和手术技术。与其他外科专业一样，胸外科正在朝着微创技术发展，这些技术正在降低发病率、死亡率和住院时间。这一进展使患者能够从大型肺部手术中更早康复。
